相关实验视频
Updated: Jun 21, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
提供者报告说,在华盛顿州,实施消除型肝炎的障碍
Paula Cox-North1, Lisa Wiggins2, Jon Stockton3
1Department of Biobehavioral Nursing and Health Informatics, University of Washington, Box 357260, Seattle, Washington, 98195, USA. paulac@uw.edu.
华盛顿州的高肝炎C (HCV) 查与低治疗率形成鲜明对比. 治疗HCV的关键障碍包括临床医生的知识差距和治疗临床医生的数量不足,阻碍了消除目标.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 虽然可以治疗C型肝炎 (HCV),但在2018年,华盛顿州仅有12%的诊断患者接受了治疗.
- 华盛顿州于2019年启动了一项HCV消除计划,以改善查和治疗机会.
研究的目的:
- 确定提供者和卫生系统在华盛顿州实施HCV查和治疗的障碍.
主要方法:
- 一项2022年在线调查评估了华盛顿州547名医疗保健提供者的HCV查和治疗实践.
- 符合条件的提供者从事初级保健,传染病,胃肠病学或社区卫生机构的实践.
- 调查问题涵盖了查/治疗实践,障碍,知识,耻辱和共同管理的意愿.
主要成果:
- 艾滋病毒查的采用率很高 (96%),报告的障碍很少.
- 只有28%的提供者在治疗HCV,而71%的患者转移到其他地方.
- 治疗障碍包括知识缺陷 (64%) 和缺乏组织支持 (24%).
结论:
- 尽管进行了大量的查,但在华盛顿州,存在重大障碍,阻碍了HCV治疗的实施.
- 缺乏治疗临床医生和临床医生知识缺陷是治疗HCV的主要障碍.
- 扩大和教育治疗HCV的临床医生工作人员对于实现到2030年消除HCV至关重要.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
相关概念视频
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Drug Elimination: Non-Renal Routes